CONMED Corp. 8-K Summary: Material Definitive Agreement
Business Context and Reporting Period
On June 10, 2025, CONMED Corporation (CNMD) entered into an Eighth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent. This filing reports the entry into a material definitive agreement and the creation of a direct financial obligation.
Key Financial Metrics and Debt Structure
The new Credit Agreement establishes the following secured facilities:
- U.S. Dollar Revolving Credit Facility: $550.0 million
- Multicurrency Revolving Credit Facility: $100.0 million
- Term Loan Facility: $100.0 million
On the closing date, CONMED drew the full $100.0 million term loan and $16.0 million from the revolving facilities to repay outstanding amounts under the previous credit agreement. The filing does not provide current revenue, profit, cash flow, or margin data.
Material Changes Versus Prior Period
The new agreement replaces the Existing Credit Agreement (dated July 16, 2021) with the following key modifications:
- Maturity Extension: Term loan and revolving credit facilities extended to June 10, 2030.
- Covenant Changes: Removed the fixed charge coverage ratio covenant; introduced a minimum interest coverage ratio of not less than 2.75 to 1.00 (tested quarterly).
- Prepayment Terms: Removed mandatory prepayments in case of excess cash flow.
- Interest Rate Margins: Updated applicable margins to 1.125% per annum for Term Benchmark Loans and Sterling Loans, and 0.125% per annum for ABR Loans.
Guidance, Risks, and Covenants
The agreement includes specific financial covenants and liquidity requirements:
- Leverage Ratios: Consolidated senior secured leverage ratio capped at 3.75 to 1.00; consolidated total leverage ratio capped at 5.50 to 1.00 (with step-ups available for material acquisitions).
- Liquidity Covenant: Commences 91 days prior to the earliest scheduled maturity of convertible notes. Requires maintaining liquidity of at least $75 million plus the aggregate principal amount of early maturing debt (if such debt exceeds $200 million).
- Events of Default: Include failure to pay principal/interest, covenant breaches, incorrect representations, defaults on other indebtedness of $50.0 million or more, uninsured judgments exceeding $50.0 million, acquisition of more than 40% of common stock, and material ERISA liabilities.
The obligations are guaranteed by certain subsidiaries and secured by liens on the assets of CONMED and the guarantors.
Investor Verification Checklist
- Verify the full text of the Eighth Amended and Restated Credit Agreement (Exhibit 10.1) for detailed definitions of "liquidity" and "early maturing debt."
- Confirm the current status and maturity dates of CONMED's convertible notes to assess the trigger date for the minimum liquidity covenant.
- Review the Amended and Restated Guarantee and Collateral Agreement (Exhibit 10.2) to identify specific subsidiaries providing guarantees and the scope of collateral.
- Monitor quarterly filings to ensure compliance with the new 2.75 to 1.00 interest coverage ratio.